Friday - April 17, 2026

Category Archives: Science

Sepsis Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Sepsis Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Sepsis pipeline landscape. It covers the Sepsis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Sepsis pipeline … Continue reading →

Microbiome Disease Clinical Trial Pipeline Accelerates as 140+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Microbiome Disease Pipeline Insights 2026” Report provides comprehensive insights about 140+ companies and 180+ pipeline drugs in Microbiome Disease pipeline landscape. It covers the Microbiome Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Shingles Treatment Pipeline Shows Strong Momentum as 18+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Shingles Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Shingles pipeline landscape. It covers the Shingles pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Shingles pipeline … Continue reading →

Malaria Treatment Pipeline Shows Strong Momentum as 15+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Malaria Pipeline Insights 2026” Report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Malaria pipeline landscape. It covers the Malaria pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Malaria pipeline therapeutics … Continue reading →

Gorlin Syndrome Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Gorlin Syndrome Pipeline Insight, 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gorlin Syndrome pipeline landscape. It covers the Gorlin Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Hepatitis C Virus Infection Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

DelveInsight’s “Hepatitis C Virus Infection Pipeline Insights 2026” Report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Hepatitis C Virus Infection pipeline landscape. It covers the Hepatitis C Virus Infection pipeline drug profiles, including clinical and nonclinical … Continue reading →

H3N2 Infection Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “H3N2 Infection Pipeline Insights 2026” Report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in H3N2 Infection pipeline landscape. It covers the H3N2 Infection pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

H1N1 Infection Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “H1N1 Infection Pipeline Insights 2026” Report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in H1N1 Infection pipeline landscape. It covers the H1N1 Infection pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →